Anti-VEGF Antibody Treatment of Glioblastoma Prolongs Survival But Results in Increased Vascular Cooption
Open Access
- 1 July 2000
- Vol. 2 (4) , 306-314
- https://doi.org/10.1038/sj.neo.7900102
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Expression of Integrin ανβ3 in Small Blood Vessels of Glioblastoma TumorsJournal of Neuropathology and Experimental Neurology, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.Proceedings of the National Academy of Sciences, 1996
- Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.Proceedings of the National Academy of Sciences, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.Journal of Clinical Investigation, 1993
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992
- Quantitative study of microvessel ultrastructure in human peritumoral brain tissueJournal of Neurosurgery, 1987